Healthcare/biotech - FastNews - Bamboo Works - China stock insights for global investors https://thebambooworks.com/category/fast-news/healthcare-biotech-fastnews/ China stock insights for global investors Fri, 17 May 2024 06:27:19 +0000 en-GB hourly 1 https://wordpress.org/?v=6.1.1 https://thebambooworks.com/wp-content/uploads/2022/12/cropped-BBW_website_icon_20221228-32x32.png Healthcare/biotech - FastNews - Bamboo Works - China stock insights for global investors https://thebambooworks.com/category/fast-news/healthcare-biotech-fastnews/ 32 32 FAST NEWS: Lepu Biopharma to raise $32 million in share sale https://thebambooworks.com/fast-news-lepu-biopharma-to-raise-32-million-in-share-sale/ Fri, 17 May 2024 05:34:10 +0000 https://thebambooworks.com/?p=32096 Lepu touts itself as the only biotech company in China working on all three very promising fronts, with PD-1 products in the new drug application (NDA) stage, multiple “smart missile” antibody-drug conjugate (ADC) products in clinical trials, and OV products under development.The Latest: Innovative drug maker Lepu Biopharma Co. Ltd. (2157.HK) announced on Friday it will place up to 51.17 million shares, or about 2.99% of its overall issued share capital, for a sale price of HK$4.58 per share. Looking Up: The company expects to receive approximately 230 million yuan ($32 million) in net proceeds from the.....

The post FAST NEWS: Lepu Biopharma to raise $32 million in share sale appeared first on Bamboo Works.

]]> FAST NEWS: Euda Health acquires CK Health in $15 million deal https://thebambooworks.com/fast-news-euda-health-acquires-ck-health-in-15-million-deal/ Mon, 13 May 2024 11:09:52 +0000 https://thebambooworks.com/?p=31945 EUDA acquires CK HealthThe Latest: Singapore-based digital health platform EUDA Health Holdings Ltd. (EUDA.US) said on Wednesday it completed its acquisition of CK Health Plus Sdn Bhd, a Malaysian provider of consumer wellness products, in a deal that values CK Health at $15 million. Looking Up: The acquisition will give EUDA an entry to the healthcare markets in.....

The post FAST NEWS: Euda Health acquires CK Health in $15 million deal appeared first on Bamboo Works.

]]> FAST NEWS: Fosun Pharma hits pause button on share buyback program https://thebambooworks.com/fast-news-fosun-pharma-hits-pause-button-on-share-buyback-program/ Tue, 07 May 2024 06:28:43 +0000 https://thebambooworks.com/?p=31722 Fosun Pharma is a diversified drug company whose portfolio includes pharmaceutical, medical equipment and healthcare services.The Latest: Shanghai Fosun Pharmaceutical (Group) Co. Ltd. (2196.HK; 600196.SH) announced Monday it hasn’t yet implemented a share buyback since announcing a plan on March 27 to buy back its A shares through centralized bidding. Looking Up: As the share buyback has not yet commenced, it has not had any impact on the company’s cash flow. Take.....

The post FAST NEWS: Fosun Pharma hits pause button on share buyback program appeared first on Bamboo Works.

]]> FAST NEWS: CanSino’s quarterly revenue rises, but loss also widens https://thebambooworks.com/fast-news-cansinos-quarterly-revenue-rises-but-loss-also-widens/ Tue, 30 Apr 2024 06:32:49 +0000 https://thebambooworks.com/?p=31419 Founded in 2009 as a vaccine manufacturer, CanSino was listed on the Hong Kong Stock Exchange in March 2019 and on the Shanghai STAR Market in August 2020.The Latest: CanSino Biologics Inc. (6185.HK; 688185.SH) reported Monday its revenue rose 13.7% year-on-year to about 114 million yuan ($15.7 million) in the first quarter, while its net loss widened 21.9% to 170 yuan million. Looking Up: The company’s R&D spending as a percentage of operating revenue decreased by 41.25 percentage points year-on-year during the period, mainly.....

The post FAST NEWS: CanSino’s quarterly revenue rises, but loss also widens appeared first on Bamboo Works.

]]> FAST NEWS: Boan Bio pledges shares as collateral for $41 million loan https://thebambooworks.com/fast-news-boan-bio-pledges-shares-as-collateral-for-41-million-loan/ Mon, 15 Apr 2024 06:45:35 +0000 https://thebambooworks.com/?p=30932 Established in 2013, Boan was acquired by Luye Pharma in 2019, and then spun off not long after that. It was listed in Hong Kong in late December 2022 after filing twice.The Latest: Shandong Boan Biotechnology Co. Ltd. (6955.HK) announced on Friday that it has entered into a loan facility with China Jingu International Trust, whereby Jingu has agreed to lend it 300 million yuan ($41.4 million). Looking Up: Boan believes the financing will enable it to rapidly develop and market a variety of products, potentially accelerating.....

The post FAST NEWS: Boan Bio pledges shares as collateral for $41 million loan appeared first on Bamboo Works.

]]> FAST NEWS: BlackRock boosts stake in battered WuXi AppTec https://thebambooworks.com/fast-news-blackrock-boosts-stake-in-battered-wuxi-apptec/ Wed, 03 Apr 2024 06:42:32 +0000 https://thebambooworks.com/?p=30597 WuXi AppTec has recently come under fire from U.S. politicians who want to ban government-backed projects from buying its services, causing the stock to lose about half of its value this year.The latest: Asset management company BlackRock Inc. purchased 618,000 Hong Kong-listed shares of WuXi AppTec Co. Ltd. (2359.HK; 603259.SH) on March 26, raising its stake in the drug outsourcing services company from 5.99% to 6.15%, according to a new Hong Kong Stock Exchange filing. Looking up: Such an increase by a major institutional buyer is usually a favorable.....

The post FAST NEWS: BlackRock boosts stake in battered WuXi AppTec appeared first on Bamboo Works.

]]> FAST NEWS: Venus Medtech’s loss narrows on surging overseas sales https://thebambooworks.com/fast-news-venus-medtechs-loss-narrows-on-surging-overseas-sales/ Tue, 02 Apr 2024 06:23:18 +0000 https://thebambooworks.com/?p=30534 ounded in 2009 and listed in Hong Kong in 2019, Venus Medtech produces and sells structural products.The latest: Medical device maker Venus Medtech (Hangzhou) Inc. (2500.HK) reported last Thursday its net loss narrowed 31.8% last year to 721 million yuan ($99.7 million). Looking up: The company’s annual revenue rose 20.9% year-on-year to 491 million yuan as it further commercialized its VenusA series of core medical devices and increased its overseas sales. Take Note:.....

The post FAST NEWS: Venus Medtech’s loss narrows on surging overseas sales appeared first on Bamboo Works.

]]> FAST NEWS: Innovent Bio’s loss narrows on strong sales growth https://thebambooworks.com/fast-news-innovent-bios-loss-narrows-on-strong-sales-growth/ Thu, 21 Mar 2024 07:06:41 +0000 https://thebambooworks.com/?p=30132 Founded in 2011 and listed on the Hong Kong Stock Exchange in 2018, Innovent develops and sells innovative drugs to treat tumors and other diseases.The latest: Biotech company Innovent Biologics Inc. (1801.HK) announced Wednesday its annual net loss last year narrowed 52.8% year-over-year to 1.03 billion yuan ($143 million), while its non-GAAP net narrowed by an even bigger 79.1% to 515 million yuan. Looking up: The company’s revenue last year jumped by 36.2% to 6.21 billion yuan as it posted strong sales.....

The post FAST NEWS: Innovent Bio’s loss narrows on strong sales growth appeared first on Bamboo Works.

]]> FAST NEWS: PW Medtech’s profit jumps on post-Covid rebound https://thebambooworks.com/fast-news-pw-medtechs-profit-jumps-on-post-covid-rebound/ Thu, 14 Mar 2024 06:38:12 +0000 https://thebambooworks.com/?p=29705 Medical device maker PW Medtech Group said on Wednesday it expects to report a net profit of 142 million yuan to 165 million yuan for last year, up 33% to 55% from 2022.The latest: Medical device maker PW Medtech Group Ltd. (1358.HK) said on Wednesday it expects to report a net profit of 142 million yuan ($19.6 million) to 165 million yuan for last year, up 33% to 55% from 2022. Looking up: The profit growth was driven by strong performance from the company’s blood purification and infusion set businesses......

The post FAST NEWS: PW Medtech’s profit jumps on post-Covid rebound appeared first on Bamboo Works.

]]> FAST NEWS: Henlius expects first-ever annual profit on strong drug sales https://thebambooworks.com/fast-news-henlius-expects-first-ever-annual-profit-on-strong-drug-sales/ Tue, 05 Mar 2024 07:05:10 +0000 https://thebambooworks.com/?p=29295 Shanghai Henlius Biotech said on Monday it expects to report a net profit of 500 million yuan or more for 2023, reversing a loss of 695 million yuan in 2022 and marking its first-ever annual profit.The latest: Shanghai Henlius Biotech Inc. (2696.HK) said on Monday it expects to report a net profit of 500 million yuan ($69.5 million) or more for 2023, reversing a loss of 695 million yuan in 2022 and marking its first-ever annual profit. Looking up: The company’s move into the black was driven by growing sales for its core.....

The post FAST NEWS: Henlius expects first-ever annual profit on strong drug sales appeared first on Bamboo Works.

]]> FAST NEWS: AIM Vaccine’s loss balloons https://thebambooworks.com/fast-news-aim-vaccines-loss-balloons/ Mon, 04 Mar 2024 07:28:05 +0000 https://thebambooworks.com/?p=29238 Vaccine maker AIM Vaccine said on Monday it expects to report a net loss of 1.25 billion yuan to 1.38 billion yuan for last year, roughly quadruple its loss from 2022.The latest: Vaccine maker AIM Vaccine Co. Ltd. (6660.HK) said on Monday it expects to report a net loss of 1.25 billion yuan ($174 million) to 1.38 billion yuan for last year, roughly quadruple its loss from 2022. Looking up: The company’s R&D spending rose significantly last year mainly due to the strong progress for its.....

The post FAST NEWS: AIM Vaccine’s loss balloons appeared first on Bamboo Works.

]]> FAST NEWS: Zai Lab’s loss narrows on strengthening sales https://thebambooworks.com/fast-news-zai-labs-loss-narrows-on-strengthening-sales/ Wed, 28 Feb 2024 07:38:19 +0000 https://thebambooworks.com/?p=28973 Biotech company Zai Lab reported Wednesday that its loss narrowed 24.5% to $335 million last year.The latest: Biotech company Zai Lab Ltd. (9688.HK; ZLAB.US) reported Wednesday that its loss narrowed 24.5% to $335 million last year. Looking up: The narrower loss owed mainly to a 25% increase in revenue to $267 million last year on higher income from its core products, Nuzyra, Qinlock and Zejula, as well as a reduction in foreign exchange losses.....

The post FAST NEWS: Zai Lab’s loss narrows on strengthening sales appeared first on Bamboo Works.

]]>